Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000905711 | SCV001050304 | likely benign | not provided | 2018-03-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000905711 | SCV001900031 | benign | not provided | 2020-02-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002434201 | SCV002746108 | likely benign | Inborn genetic diseases | 2018-07-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV003338859 | SCV004049797 | likely benign | Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004551753 | SCV004793853 | likely benign | POGZ-related disorder | 2023-09-29 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |